| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA5255869 | B | Inhibition of SARS-CoV-2 main protease using MCA-AVLQSGFR-Lys(Dnp)-Lys-NH2 as substrate by FRET analysis | Severe acute respiratory syndrome coronavirus 2 | 2 | single protein format | Scientific Literature | ||
| 2. | ALA5255870 | B | Inhibition of SARS-CoV-2 main protease by FRET analysis | Severe acute respiratory syndrome coronavirus 2 | 5 | single protein format | Scientific Literature | ||
| 3. | ALA5255871 | B | Inhibition of SARS-CoV-2 main protease expressed in Escherichia coli BL21 (DE3) using MDA-AVLQSGFR-Lys(Dnp)-Lys-NH2 as substrate incubated for 10 mins by FRET analysis | Severe acute respiratory syndrome coronavirus 2 | 27 | assay format | Scientific Literature | ||
| 4. | ALA5256312 | B | Inhibition of SARS-CoV-2 nsp14 guanine-N7-methyltransferase activity | Severe acute respiratory syndrome coronavirus 2 | 3 | single protein format | Scientific Literature | ||
| 5. | ALA5256313 | B | Inhibition of wild type SARS-CoV2 main protease by measuring luciferase signal at 10 uM by reverse-nanoluciferase reporter assay | Severe acute respiratory syndrome coronavirus 2 | 2 | single protein format | Scientific Literature | ||
| 6. | ALA5256314 | B | Inhibition of wild type SARS-CoV2 main protease by measuring luciferase signal at 0.02 to 125 uM by reverse-nanoluciferase reporter assay | Severe acute respiratory syndrome coronavirus 2 | 2 | single protein format | Scientific Literature | ||
| 7. | ALA5254921 | B | Inhibition of SARS-CoV-2 3CL protease | Severe acute respiratory syndrome coronavirus 2 | 6 | single protein format | Scientific Literature | ||
| 8. | ALA5254928 | B | Inhibition of SARS-CoV-2 3CL protease measured after 10 mins by FRET assay | Severe acute respiratory syndrome coronavirus 2 | 2 | single protein format | Scientific Literature | ||
| 9. | ALA5254929 | B | Inhibition of SARS-CoV-2 3CL protease assessed as inhibition constant | Severe acute respiratory syndrome coronavirus 2 | 1 | single protein format | Scientific Literature | ||
| 10. | ALA5254932 | B | Inhibition of SARS-CoV-2 3CL protease by FRET assay | Severe acute respiratory syndrome coronavirus 2 | 1 | single protein format | Scientific Literature | ||
| 11. | ALA5254934 | B | Inhibition of SARS-CoV-2 3CL protease expressed in escherichia coli measured after 24 hrs by SDS-PAGE | Severe acute respiratory syndrome coronavirus 2 | 1 | assay format | Scientific Literature | ||
| 12. | ALA5254935 | B | Inhibition of SARS-CoV-2 3CL protease using HiLyte Fluor488TM-ESATLQSGLRKAK-QXL520TM-NH2 as substrate measured after 5 hrs by FRET assay | Severe acute respiratory syndrome coronavirus 2 | 1 | single protein format | Scientific Literature | ||
| 13. | ALA5254937 | B | Inhibition of SARS-CoV-2 HKU-001a 3CL protease | Severe acute respiratory syndrome coronavirus 2 | 1 | single protein format | Scientific Literature | ||
| 14. | ALA5257298 | B | Inhibition of SARS-CoV-2 3CL protease using DabcylKTSAVLQSGFRKME-Edans amide as substrate by FRET assay | Severe acute respiratory syndrome coronavirus 2 | 2 | single protein format | Scientific Literature | ||
| 15. | ALA5257300 | B | Inhibition of SARS-CoV-2 3CL protease using 2-aminobenzoyl-SVTLQSG-Tyr(NO2)-R as substrate | Severe acute respiratory syndrome coronavirus 2 | 5 | single protein format | Scientific Literature | ||
| 16. | ALA5257301 | B | Inhibition of SARS-CoV-2 3CL protease expressed in african green monkey Vero cells by plaque reduction assay | Severe acute respiratory syndrome coronavirus 2 | 1 | cell-based format | Scientific Literature | ||
| 17. | ALA5257302 | B | Inhibition of SARS-CoV-2 3CL protease using Dabcyl-Leu-Ala-Gln-Ala-Val-Arg-Ser-Ser-Ser-Arg-Edans as substrate | Severe acute respiratory syndrome coronavirus 2 | 1 | single protein format | Scientific Literature | ||
| 18. | ALA5257308 | B | Inhibition of SARS-CoV-2 3CL protease using (E-EDANS)RELNGGAPI(K-DABCYL)S EDANS as substrate by FRET assay | Severe acute respiratory syndrome coronavirus 2 | 3 | single protein format | Scientific Literature | ||
| 19. | ALA5257309 | B | Inhibition of N terminal his tagged SARS-CoV-2 3CL protease by FRET assay | Severe acute respiratory syndrome coronavirus 2 | 5 | single protein format | Scientific Literature | ||
| 20. | ALA5257310 | B | Inhibition of SARS-CoV-2 3CL protease using Dabcyl-KTSAVLQSGFRKME-Edans as substrate assessed as inhibition constant by flurogenic assay | Severe acute respiratory syndrome coronavirus 2 | 1 | single protein format | Scientific Literature |
The page will load shortly, Thanks for your patience!